Zioxtenzo

Random entry RSS

Posted in:
News

Sandoz’s Application for Neulasta® (pegfilgrastim) Accepted for Review in Europe
By Seth Cockrum October 30, 2017 Comments are off
Sandoz announced that its biosimilar application for Neulasta® (pegfilgrastim) has been accepted for regulatory review by the European...

Read more

Tagged with: EMA, Neulasta®, pegfilgrastim, Sandoz, Zioxtenzo

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top